CSE1L and colorectal carcinoma: In conclusion, our study elucidated that BANCR silencing hampered CRC progression and enhanced ADR sensitivity at least partly by regulating miR-203/CSE1L in vitro and in vivo. Targeting BANCR might be a potential therapeutic target for CRC management.